Ginza Phoenix Clinic: NK Cell Immunotherapy and Stem Cell Regeneration

Ginza Phoenix Clinic, located in Tokyo's Ginza district, integrates dual expertise: advanced cancer immunotherapy and regenerative stem cell medicine. Led by physicians with extensive regenerative medicine research backgrounds, the clinic explores therapeutic possibilities beyond standard cancer protocols.

Primary Treatment Domains

High-Activity NK Cell Immunotherapy: NK cells (natural killer cells) function as first-line immune defense.

• Superior tumor recognition: Active attack on MHC class I-deficient cancers (escaping T cell surveillance)
• Synergistic mechanisms: NK cells enhance monoclonal antibody (Herceptin, Rituxan) cytotoxicity via antibody-dependent cellular cytotoxicity (ADCC)
• Extended culture advantage: Proprietary 3-week expansion protocols achieve superior cell viability and yield versus standard methods

Mesenchymal Stem Cell (MSC) Therapy: Addresses tissue regeneration and repair needs with regulatory-compliant stem cell protocols.

• Differentiation and proliferation: Self-renewal capacity supports organ function restoration after cancer treatment or age-related damage
• Quality control: In-house cell culture center maintains rigorous standards ensuring reinfusion cell safety and high viability

Professional Certifications

Ginza Phoenix Clinic holds Japanese Ministry of Labor certifications for Class II and III regenerative medicine. All cell processing occurs under strict on-site quality control, ensuring medical process professionalism and safety.

Data Source

Ginza Phoenix Clinic Regenerative Medicine Program

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).